SPRC
SciSparc Ltd.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R Mar 10 SciSparc Ltd. (SPRC) announced that its majority-owned subsidiary, N…
- S Jun 1 1 insider sell $4.6K at $10.00
- X Jul 31 Short interest jumps 277.7% to 38.0K
- X Aug 14 Short interest falls 54.7% to 17.2K
- X Sep 15 Short interest falls 29.0% to 11.0K
- R Sep 30 SciSparc filed its H1 2026 interim financials, reporting a net loss…
- R Oct 15 SciSparc entered into an inducement letter with L.I.A Pure Capital L…
- E Oct 15 Trading halt: Halt Resumed: SPRC — trading resumed after LUDP (Volatilit…
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider sold $4.6K.
- InstitutionsMIXED
Q2 2026: 1 added (0 new), 0 trimmed or exited.
- TrendDOWNTREND
77% below its 50-day average. New closing low $1.09 on Oct 23.
- SocialQUIET
No Reddit mentions this week. Last mention Oct 15.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| UBS Group AG | ADD | $24.9K |
Quarterly 13F filings are due 45 days after each quarter ends.
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 1, 2026 | Shrem Itschak Director | SELL | $4.6K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026| Oct 15, 2026 | Volatility Pause | Resumed |
| Oct 15, 2026 | Volatility Pause | Resumed |
| Oct 15, 2026 | Volatility Pause | Resumed |
| Oct 15, 2026 | Volatility Pause | Resumed |
| Oct 15, 2026 | Volatility Pause | Resumed |
SecBot reports
16 filings · 11 press releases · 0 bullish · 3 bearish · 13 neutral- BEARISH 6-KOct 26, 2026
SciSparc entered into an inducement letter with L.I.A Pure Capital to exercise warrants for 405,728 shares at a reduced price of $1.0 per share (down from $4.929), raising approximately $405,728 in gross proceeds. The exercise is dilutive, adding ~20% to the current share count of 2,057,719, but…
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL 6-KOct 23, 2026
SciSparc subsidiary NeuroThera Labs announced operational progress in its FDA-approved Phase IIb…
This is a routine operational update with no financial data or efficacy readout. Monitor for actual patient enrollment announcements and eventual Phase IIb data, but the current filing provides no…
- NEUTRAL PRESS RELEASEOct 22, 2026
SciSparc subsidiary NeuroThera Labs announced completion of manufacturing and QP batch release…
Monitor for the first patient enrolled announcement and any future Phase IIb top-line data readout, which would be the next binary catalyst for SPRC. The QP release is a necessary but…
- BEARISH 6-KOct 15, 2026
SciSparc entered into an inducement letter with L.I.A Pure Capital Ltd. to convert $2,023,039.21…
The conversion eliminates $2.0M of debt but at the cost of extreme dilution (~369% increase in shares outstanding). With the shares registered for resale, the holder can sell immediately, creating…
All SPRC filing & press-release reports (27)
- 6-K reportOct 26, 2026
- 6-K reportOct 23, 2026
- PRESS-RELEASE reportOct 22, 2026
- 6-K reportOct 15, 2026
- 6-K reportOct 15, 2026
- PRESS-RELEASE reportOct 15, 2026
- 6-K reportOct 7, 2026
- 6-K reportSep 30, 2026
- 6-K reportSep 24, 2026
- PRESS-RELEASE reportSep 23, 2026
- 6-K reportAug 26, 2026
- 6-K reportAug 24, 2026
- PRESS-RELEASE reportAug 18, 2026
- 6-K reportAug 12, 2026
- 6-K reportAug 5, 2026
- 6-K reportJul 29, 2026
- PRESS-RELEASE reportJul 29, 2026
- 6-K reportJul 15, 2026
- PRESS-RELEASE reportJul 15, 2026
- 3/A reportJul 13, 2026
- 6-K reportJun 4, 2026
- PRESS-RELEASE reportJun 4, 2026
- 6-K reportMay 29, 2026
- PRESS-RELEASE reportMay 28, 2026
- PRESS-RELEASE reportMar 16, 2026
- PRESS-RELEASE reportMar 12, 2026
- PRESS-RELEASE reportMar 10, 2026